Atrás
Rango del Día
$21.27
$23.46
Rango de 52 Semanas
$10.57
$23.77
Volumen
5,398,763
Promedio 50D / 200D
$20.15
/
$16.67
Cierre Anterior
$20.97
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.0 | 0.2 |
| P/B | 3.5 | 3.0 |
| ROE % | -45.7 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$34.40
+53.1%
Low: $25.00
High: $40.00
EPS Futuro
-$2.72
Ingresos Est.
50.59M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.83
-$0.15 – $5.02
|
1.07B | 5 |
| FY2029 |
$0.25
-$0.02 – $0.70
|
698.58M | 11 |
| FY2028 |
-$0.69
-$2.17 – $1.30
|
506.19M | 13 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -$0.74 | -$0.73 | +0.9% |
| 2025-11-06 | -$0.76 | -$0.74 | +2.6% |
| 2025-08-11 | -$0.74 | -$0.72 | +2.7% |
| 2025-05-06 | -$0.71 | -$0.78 | -9.9% |
| 2025-02-27 | -$0.75 | -$0.67 | +10.7% |
| 2024-11-06 | -$0.60 | -$0.63 | -5.0% |
| 2024-08-01 | -$0.68 | -$0.59 | +13.2% |
| 2024-05-07 | -$0.67 | -$0.68 | -1.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -422.10M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-45.69%
ROIC-39.44%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.04
Current Ratio9.16
Interest Coverage0.00
Valoración
P/E Ratio
-6.95
Forward P/EN/A
P/B Ratio3.52
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -512.54M |
| ROE | -45.69% | ROA | -44.77% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -422.10M |
| ROIC | -39.44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 9.16 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6.95 | Forward P/E | N/A |
| P/B Ratio | 3.52 | P/S Ratio | N/A |
| PEG Ratio | -0.36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 70.44 | Fwd Earnings Yield | N/A |
| FCF Yield | -11.85% | ||
| Market Cap | 3.56B | Enterprise Value | 3.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 330.53M | 108.46M | 48.66M |
| Net Income | -512.54M | -422.77M | -145.22M | -325.99M | -290.58M |
| EPS (Diluted) | -2.97 | -2.57 | -1.06 | -2.60 | -2.39 |
| Gross Profit | -11.18M | 0.0 | 330.53M | 108.46M | 48.66M |
| Operating Income | -555.34M | -487.34M | -196.70M | -340.74M | -295.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B |
| Total Liabilities | 131.09M | 144.50M | 122.96M | 417.81M | 441.87M |
| Shareholders' Equity | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
| Total Debt | 42.29M | 48.71M | 52.24M | 60.35M | 64.01M |
| Cash & Equivalents | 205.33M | 174.96M | 127.11M | 218.04M | 293.48M |
| Current Assets | 900.66M | 864.44M | 1.06B | 1.37B | 897.23M |
| Current Liabilities | 98.35M | 102.21M | 77.98M | 363.92M | 378.25M |